GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Conditions : AD Interventions : Drug: SSGJ-716; Drug: Placebo Sponsors : Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Recruiting

Alison Quinn's Respiro Diagnostics raises GBP 1M for breath-based lung diagnostics

The UK company plans a September 2026 lung cancer clinical study after early proof-of-concept work in mesothelioma patients.

A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma

Conditions : Glioma; Adult Interventions : Drug: HF1K16 Sponsors : HighField Biopharmaceuticals Corporation Not yet recruiting

<![CDATA[Epcoritamab/R2 Earns European Approval for R/R Follicular Lymphoma]]>

<![CDATA[EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process]]>

South Korea’s AimedBio Invests in Inocras, Partners on WGS for Cancer Trials

The companies hope to find patients likely to respond to AimedBio’s antibody-drug conjugates.